TFG Advisers’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,753
| Closed | -$220K | – | 198 |
|
|
2024
Q1 | $220K | Sell |
2,753
-118
| -4% | -$9.41K | 0.09% | 194 |
|
|
2023
Q4 | $227K | Sell |
2,871
-223
| -7% | -$17.6K | 0.1% | 184 |
|
|
2023
Q3 | $216K | Buy |
3,094
+19
| +0.6% | +$1.33K | 0.1% | 181 |
|
|
2023
Q2 | $213K | Sell |
3,075
-180
| -6% | -$12.4K | 0.1% | 189 |
|
|
2023
Q1 | $242K | Sell |
3,255
-904
| -22% | -$67.2K | 0.12% | 178 |
|
|
2022
Q4 | $388K | Buy |
4,159
+16
| +0.4% | +$1.49K | 0.2% | 116 |
|
|
2022
Q3 | $395K | Buy |
4,143
+62
| +2% | +$5.91K | 0.22% | 112 |
|
|
2022
Q2 | $378K | Buy |
4,081
+15
| +0.4% | +$1.39K | 0.2% | 119 |
|
|
2022
Q1 | $412K | Buy |
4,066
+113
| +3% | +$11.5K | 0.19% | 125 |
|
|
2021
Q4 | $408K | Buy |
3,953
+13
| +0.3% | +$1.34K | 0.18% | 132 |
|
|
2021
Q3 | $334K | Buy |
3,940
+14
| +0.4% | +$1.19K | 0.16% | 143 |
|
|
2021
Q2 | $328K | Sell |
3,926
-99
| -2% | -$8.27K | 0.16% | 142 |
|
|
2021
Q1 | $303K | Sell |
4,025
-107
| -3% | -$8.06K | 0.16% | 147 |
|
|
2020
Q4 | $282K | Buy |
4,132
+24
| +0.6% | +$1.64K | 0.15% | 149 |
|
|
2020
Q3 | $239K | Buy |
4,108
+196
| +5% | +$11.4K | 0.14% | 152 |
|
|
2020
Q2 | $254K | Buy |
+3,912
| New | +$254K | 0.16% | 135 |
|
|
2020
Q1 | – | Sell |
-3,143
| Closed | -$233K | – | 207 |
|
|
2019
Q4 | $233K | Buy |
+3,143
| New | +$233K | 0.13% | 146 |
|